Logo image of 1CVA.MI

CLEVELAND-CLIFFS INC (1CVA.MI) Stock Fundamental Analysis

BIT:1CVA - Euronext Milan - US1858991011 - Common Stock - Currency: EUR

7.492  +0.67 (+9.89%)

Fundamental Rating

2

Overall 1CVA gets a fundamental rating of 2 out of 10. We evaluated 1CVA against 40 industry peers in the Metals & Mining industry. Both the profitability and financial health of 1CVA have multiple concerns. 1CVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year 1CVA has reported negative net income.
1CVA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1CVA reported negative net income in multiple years.
Of the past 5 years 1CVA 4 years had a positive operating cash flow.
1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

The Return On Assets of 1CVA (-5.67%) is worse than 82.50% of its industry peers.
1CVA has a worse Return On Equity (-18.90%) than 85.00% of its industry peers.
Industry RankSector Rank
ROA -5.67%
ROE -18.9%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
1CVA.MI Yearly ROA, ROE, ROIC1CVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

1CVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1CVA.MI Yearly Profit, Operating, Gross Margins1CVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

1CVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1CVA has been reduced compared to 1 year ago.
1CVA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CVA has a worse debt to assets ratio.
1CVA.MI Yearly Shares Outstanding1CVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1CVA.MI Yearly Total Debt VS Total Assets1CVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1CVA has an Altman-Z score of 1.13. This is a bad value and indicates that 1CVA is not financially healthy and even has some risk of bankruptcy.
1CVA's Altman-Z score of 1.13 is on the low side compared to the rest of the industry. 1CVA is outperformed by 77.50% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that 1CVA has dependencies on debt financing.
With a Debt to Equity ratio value of 1.22, 1CVA is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z 1.13
ROIC/WACCN/A
WACC8.6%
1CVA.MI Yearly LT Debt VS Equity VS FCF1CVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

1CVA has a Current Ratio of 2.13. This indicates that 1CVA is financially healthy and has no problem in meeting its short term obligations.
1CVA's Current ratio of 2.13 is fine compared to the rest of the industry. 1CVA outperforms 75.00% of its industry peers.
1CVA has a Quick Ratio of 2.13. This is a bad value and indicates that 1CVA is not financially healthy enough and could expect problems in meeting its short term obligations.
1CVA has a worse Quick ratio (0.64) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 0.64
1CVA.MI Yearly Current Assets VS Current Liabilites1CVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

1CVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -284.85%.
Looking at the last year, 1CVA shows a very negative growth in Revenue. The Revenue has decreased by -15.00% in the last year.
The Revenue has been growing by 57.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
Revenue 1Y (TTM)-15%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%

3.2 Future

1CVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.61% yearly.
Based on estimates for the next years, 1CVA will show a small growth in Revenue. The Revenue will grow by 1.94% on average per year.
EPS Next Y-16.4%
EPS Next 2Y50.44%
EPS Next 3Y36.61%
EPS Next 5YN/A
Revenue Next Year2.4%
Revenue Next 2Y4.25%
Revenue Next 3Y4.64%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVA.MI Yearly Revenue VS Estimates1CVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
1CVA.MI Yearly EPS VS Estimates1CVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for 1CVA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 26.17 indicates a quite expensive valuation of 1CVA.
60.00% of the companies in the same industry are cheaper than 1CVA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, 1CVA is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 26.17
1CVA.MI Price Earnings VS Forward Price Earnings1CVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1CVA.MI Per share data1CVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

1CVA's earnings are expected to grow with 36.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.44%
EPS Next 3Y36.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1CVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEVELAND-CLIFFS INC

BIT:1CVA (7/9/2025, 7:00:00 PM)

7.492

+0.67 (+9.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-18 2025-07-18/amc
Inst Owners74.61%
Inst Owner ChangeN/A
Ins Owners1.64%
Ins Owner ChangeN/A
Market Cap3.71B
Analysts65.56
Price Target8.66 (15.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.82%
Min EPS beat(2)-49.04%
Max EPS beat(2)-28.61%
EPS beat(4)1
Avg EPS beat(4)-17.14%
Min EPS beat(4)-90.92%
Max EPS beat(4)100%
EPS beat(8)3
Avg EPS beat(8)-6.5%
EPS beat(12)4
Avg EPS beat(12)-8.8%
EPS beat(16)6
Avg EPS beat(16)-8.33%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.31%
Max Revenue beat(2)-1.15%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-5.15%
Max Revenue beat(4)-1.15%
Revenue beat(8)1
Avg Revenue beat(8)-2.01%
Revenue beat(12)3
Avg Revenue beat(12)-1.71%
Revenue beat(16)5
Avg Revenue beat(16)-0.94%
PT rev (1m)-14.61%
PT rev (3m)-35.11%
EPS NQ rev (1m)-117.95%
EPS NQ rev (3m)-2624.56%
EPS NY rev (1m)-49.09%
EPS NY rev (3m)-910.05%
Revenue NQ rev (1m)-1.21%
Revenue NQ rev (3m)-2.02%
Revenue NY rev (1m)-1.63%
Revenue NY rev (3m)-3.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 26.17
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)0.29
Fwd EY3.82%
FCF(TTM)-1.84
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS32.5
BVpS10.92
TBVpS5.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.67%
ROE -18.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.3%
Cap/Sales 3.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 0.64
Altman-Z 1.13
F-Score3
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-284.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-655.56%
EPS Next Y-16.4%
EPS Next 2Y50.44%
EPS Next 3Y36.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-15%
Revenue growth 3Y-2.1%
Revenue growth 5Y57.33%
Sales Q2Q%-10.96%
Revenue Next Year2.4%
Revenue Next 2Y4.25%
Revenue Next 3Y4.64%
Revenue Next 5Y1.94%
EBIT growth 1Y-223.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year271.12%
EBIT Next 3Y82.56%
EBIT Next 5Y47.39%
FCF growth 1Y-210.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-120.96%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%